March 22, 2010
European Association of Urology
Catheter-associated urinary tract infections. In: Guidelines on urological infections. This updates a previously published guideline summary.
Complicated urinary tract infections due to urological disorders. In: Guidelines on urological infections. This updates a previously published guideline summary.
Epididymitis and orchitis. In: Guidelines on urological infections. This updates a previously published guideline summary.
Peri-operative antibacterial prophylaxis in urology. In: Guidelines on urological infections. This updates a previously published guideline summary.
Prostatitis and chronic pelvic pain syndrome. In: Guidelines on urological infections. This updates a previously published guideline summary.
Sepsis syndrome in urology (urosepsis). In: Guidelines on urological infections. This updates a previously published guideline summary.
Sexually transmitted infections. In: Guidelines on urological infections.
Specific infections. In: Guidelines on urological infections.
Uncomplicated urinary tract infections in adults. In: Guidelines on urological infections. This updates a previously published guideline summary.
Urethritis. In: Guidelines on urological infections. This updates a previously published guideline summary.
Urinary tract infections in children. In: Guidelines on urological infections. This updates a previously published guideline summary.
Urinary tract infections in renal insufficiency, transplant recipients, diabetes mellitus and immunosuppression. In: Guidelines on urological infections. This updates a previously published guideline summary.
Guideline Synthesis
Updated synthesis on
Assessment and Management of Urinary Incontinence in Women, includes recommendations from NICE and SOGC.
Newly Submitted
Health Awareness Topics - March 2010
Of interest this week:
March 24 is
American Diabetes Alert Day: See the
Frequently Requested Searches page for various diabetes-related guidelines.
Inclusion Criteria
NGC is currently re-evaluating our definition of clinical practice guideline and inclusion criteria. This work will be informed by a number of efforts, such as review of the literature, guidance from the NGC/NQMC Editorial Board, previous and ongoing studies of the Institute of Medicine, and your input. We invite you to send your comments on this matter to
info@guideline.gov.
NGC Spotlight
Visit the
Preventing Hospital-Acquired Conditions page for evidence-based resources available on the NGC Web site to assist users in the prevention of the CMS-identified hospital-acquired conditions.
H1N1 Flu
Visit the
CDC Web site for the latest information on H1N1 flu including new interim guidance on
infection control measures for 2009 H1N1 influenza in healthcare settings and updated interim recommendations on
H1N1 influenza and HIV-infected adults and adolescents.
Conference News
The
Guidelines International Network (G-I-N) Conference 2010, will be held
August 25-28, 2010 in Chicago, Illinois (USA).
Register online now. The G-I-N Conference 2010 will bring together various professionals involved in evidence synthesis, guideline development, implementation, quality improvement, and health policy to integrate knowledge and, ultimately, improve patient outcomes. For further information and details, please visit the
G-I-N Conference 2010 Web site.
Healthy People 2010
See NGC's
Frequently Requested Search page for a selection of pre-set searches of NGC for guidelines related to the
Healthy People 2010 focus areas, as well as other public health and patient safety topics.
Recent U.S. Food and Drug Administration (FDA) Advisories
- March 19, 2010: Zocor (simvastatin): FDA notified healthcare professionals and patients that there is an increased risk of muscle injury in patients taking the highest approved dose of Zocor (simvastatin) 80 mg, compared to patients taking lower doses of simvastatin and possibly other drugs in the "statin" class.
- March 12, 2010: Plavix (clopidogrel): FDA notified healthcare professionals and patients that a Boxed Warning has been added to the prescribing information.
- March 11, 2010: Oral Bisphosphonates: FDA recommends that healthcare professionals follow the recommendations in the drug label when prescribing oral bisphosphonates. Patients should continue taking oral bisphosphonates unless told by their healthcare professional to stop.
NGC's Sister Resources
Find Innovations and
QualityTools classified by disease or clinical category, patient population, stage of care, setting of care, and more in AHRQ's
Health Care Innovations Exchange Web site.
Look for Quality Measures in AHRQ's
National Quality Measures Clearinghouse (NQMC).
Other Resources
To locate a previous issue of "What's New This Week," go to the
What's New Archive.
Questions or suggestions about the "What's New" feature are welcome -- please send e-mail to:
info@guideline.gov.
Submit your guidelines for inclusion in the National Guideline Clearinghouse!
Subscriptions
To sign up for our weekly NGC Update Service or to manage your subscriptions, visit the
Subscription Management page.
